logo-loader

ImmuPharma CEO still open to big pharma deal

Published: 12:25 22 Jan 2015 GMT

Dimitri Dimitriou, the chief executive of ImmuPharma (LON:IMM), insists the door is not closed on a possible deal with a large pharmaceutical group after unveiling a joint venture agreement with  Simbec-Orion, a research group that specialises in rare and orphan conditions.

‘Watch this space because there will be other deals coming along,’ says Dimitriou.

ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug...

ImmuPharma PLC (AIM:IMM) chief executive Tim McCarthy provides an extensive update during an interview with Proactive's Stephen Gunnion, focusing on the financial, business, and portfolio developments of the company. McCarthy clarified that the company is in a strong financial position,...

3 weeks, 1 day ago